| Company Name: | NBTY, Inc. | | Ticker Symbol: | NTY | | | WWW Address: | www.nbty.com | | CEO: | Scott Rudolph | | No. of Employees: | 13,760 | | Common Issue Type: | CS | | Business Description: | The Company is a global manufacturer, marketer and retailer of a line of value-priced nutritional supplements in the United States and throughout the world.
|
| | | Industry Information: | DRUGS - Drug Related Products & Accessories [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 42.5 |  0.29 | 38.6 | 45.05 | 42.4 | 42.82 | 41.75 | 512638 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 2,630.8 | 61.9 | 1.58 | 2.30 | 0.00 | 18.5 | 0.0 | 43.71 - 12.22 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 42.50 | $ | | PE Ratio - LTM | 18.5 | |
| Market Capitalisation | 2,629.6 | mil |
| Latest Shares Outstanding | 61.9 | mil |
| Earnings pS (EPS) | 2.30 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 0 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 55.8 | mil |
| Float as % of Shares Outstanding | 90.2 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 34.80 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.40 | % |
| Gross Profit Margin | 45.9 | % |
| EBITDA Margin | 10.8 | % |
| Pre-Tax Profit Margin | 6.2 | % |
| Assets Turnover | 1.5 | % |
| Return on Assets (ROA) | 5.3 | % |
| Return on Equity (ROE) | 9.4 | % |
| Return on Capital Invested (ROCI) | 6.6 | % |
| Current Ratio | 3.2 | |
| Leverage Ratio (Assets/Equity) | 1.8 | |
| Interest Cover | 5.5 | |
| Total Debt/Equity (Gearing Ratio) | 0.45 | |
| LT Debt/Total Capital | 30.0 | % |
| Working Capital pS | 9.92 | $ |
| Cash pS | 1.13 | $ |
| Book-Value pS | 17.24 | $ |
| Tangible Book-Value pS | 8.27 | $ |
| Cash Flow pS | 2.79 | $ |
| Free Cash Flow pS | -5.59 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 2.47 | |
| Price/Tangible Book Ratio | 5.14 | |
| Price/Cash Flow | 15.2 | |
| Price/Free Cash Flow | -7.6 | |
| P/E as % of Industry Group | 82.0 | % |
| P/E as % of Sector Segment | 32.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 1.6 | 100 | 8,695 | 18,347 |
| 4 Weeks | 43.71 | 35.52 | 36.41 | 16.7 | 109 | 9,308 | 158,233 |
| 13 Weeks | 43.71 | 35.52 | 37.42 | 13.6 | 106 | 5,852 | 356,972 |
| 26 Weeks | 43.71 | 24.85 | 24.69 | 72.1 | 143 | 5,590 | 698,765 |
| 52 Weeks | 43.71 | 12.22 | 14.57 | 191.7 | 236 | 6,777 | 1,687,475 |
| YTD | 43.71 | 12.22 | - | 171.6 | 222 | 6,493 | 1,473,871 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 42.52 | 42.01 | 40.18 | 34.13 | 29.17 | 1.58 | 1.84 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 8.89 | 95.9 | 10.85 |
| Income | 13.85 | 48.5 | 8.31 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 5.96 | NA | 38.89 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 9.52 | NA | 4.68 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 18.5 | 12.1 | 8.2 |
| Earnings % | -4.8 | 259.9 | -4.8 |
| EPS % | -1.3 | 266.7 | -1.3 |
| EPS $ | -0.03 | 0.72 | -0.03 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 34.41 |
| Current Ratio | 3.1 |
| Quick Ratio (Acid Test) | 0.8 |
| Liquidity Ratio (Cash) | 0.33 |
| Receivables Turnover | 18.5 |
| Average Collection Period | 19 |
| Working Capital/Equity | 59.8 |
| Working Capital pS | 10.90 |
| Cash-Flow pS | 0.00 |
| Free Cash-Flow pS | 1.73 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 4.05 |
| Financial Leverage Ratio (Assets/Equity) | 1.7 |
| Debt Ratio | 42.5 |
| Total Debt/Equity (Gearing Ratio) | 0.42 |
| LT Debt/Equity | 0.39 |
| LT Debt/Capital Invested | 32.5 |
| LT Debt/Total Liabilities | 52.6 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 2.13 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 22.40 |
| Tobin's Q Ratio | 1.34 |
| Current P/E Ratio - LTM | 18.50 |
| Enterprise Value (EV)/EBITDA | 10.05 |
| Enterprise Value (EV)/Free Cash Flow | 47.74 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 5.14 |
| Price/Book Ratio - LTM | 2.47 |
| Price/Cash Flow Ratio | 15.2 |
| Price/Free Cash Flow Ratio - LTM | -7.6 |
| Price/Sales Ratio | 1.02 |
| P/E Ratio (1 month ago) - LTM | 17.6 |
| P/E Ratio (26 weeks ago) - LTM | 15.7 |
| P/E Ratio (52 weeks ago) - LTM | 6.3 |
| 5-Y High P/E Ratio | 25.8 |
| 5-Y Low P/E Ratio | 5.3 |
| 5-Y Average P/E Ratio | 16.5 |
| Current P/E Ratio as % of 5-Y Average P/E | 112 |
| P/E as % of Industry Group | 82.0 |
| P/E as % of Sector Segment | 32.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 24.8 |
| PER SHARE FIGURES |
| LT Debt pS | 7.07 |
| Current Liabilities pS | 5.24 |
| Tangible Book Value pS - LTM | 8.27 |
| Book Value pS - LTM | 17.24 |
| Capital Invested pS | 25.30 |
| Cash pS - LTM | 1.13 |
| Cash Flow pS - LTM | 2.79 |
| Free Cash Flow pS - LTM | -5.59 |
| Earnings pS (EPS) | 2.30 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 4.14 |
| Free Cash Flow Margin 5YEAR AVG | 1.45 |
| Net Profit Margin | 5.6 |
| Net Profit Margin - 5YEAR AVRG. | 6.7 |
| Equity Productivity | 2.29 |
| Return on Equity (ROE) | 12.9 |
| Return on Equity (ROE) - 5YEAR AVRG. | 15.6 |
| Capital Invested Productivity | 1.65 |
| Return on Capital Invested (ROCI) | 9.3 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 11.2 |
| Assets Productivity | 1.30 |
| Return on Assets (ROA) | 7.4 |
| Return on Assets (ROA) - 5YEAR AVRG. | 8.8 |
| Gross Profit Margin | 45.9 |
| Gross Profit Margin - 5YEAR AVRG. | 52.7 |
| EBITDA Margin - LTM | 10.8 |
| EBIT Margin - LTM | 7.5 |
| Pre-Tax Profit Margin | 0.0 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 10.3 |
| Effective Tax Rate | 36.4 |
| Effective Tax Rate - 5YEAR AVRG. | 32.6 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 22 |
| Revenue per Employee | 0 |
| Net Income per Employee | 0 |
| Average Collection Period | 22 |
| Receivables Turnover | 18.5 |
| Day's Inventory Turnover Ratio | 0 |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 25.5 |
| Accounts Payble/Sales | 4.98 |
| Assets/Revenue | 0.77 |
| Net Working Capital Turnover | 3.83 |
| Fixed Assets Turnover | 2.68 |
| Total Assets Turnover | 1.3 |
| Revenue per $ Cash | 24.36 |
| Revenue per $ Plant | 6.91 |
| Revenue per $ Common Equity | 2.29 |
| Revenue per $ Capital Invested | 1.65 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 0.0 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 38.3 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |